Noa Therapeutics Inc. (Noa) is a preclinical Canadian biotech company aiming to defy the convention of traditional drug development to revolutionize treatment options for those living with complex inflammatory skin diseases. Leveraging intelligent design, Noa is pioneering the development of multimodal therapeutics; a singularly radical approach to address unmet needs and unlock opportunities within underserved and untapped markets. Targeting a first use case in atopic dermatitis, Noa’s non-steroidal small molecules aim to simultaneously addressing three constructive therapeutic targets. Through this multilateral approach, Noa strives to provide meaningful outcomes and establish a new, inclusive, standard for the first-line-treatment of inflammatory skin disease. 

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Therapeutics

Noa Therapeutics

Noa Therapeutics' headquarters in Toronto, Canada

Carla Spina

Annie Chevrier

Serena Mandla

This department consists of top-level executives who set the strategic direction and oversee the overall management of the organization.

Executive Leadership

This department focuses on developing and implementing strategies for pre-clinical research and development.

Noa Therapeutics

Org chart

Teams

Executive Leadership

Clinical Strategy

Offices

Noa Therapeutics

Org chart

Teams

Executive Leadership

Clinical Strategy

Offices

Related companies